344 related articles for article (PubMed ID: 10964861)
21. A double-blind comparison of paroxetine, imipramine, and placebo in major depression.
Shrivastava RK; Shrivastava SH; Overweg N; Blumhardt CL
J Clin Psychiatry; 1992 Feb; 53 Suppl():48-51. PubMed ID: 1531825
[TBL] [Abstract][Full Text] [Related]
22. Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders.
Hoehn-Saric R; Ninan P; Black DW; Stahl S; Greist JH; Lydiard B; McElroy S; Zajecka J; Chapman D; Clary C; Harrison W
Arch Gen Psychiatry; 2000 Jan; 57(1):76-82. PubMed ID: 10632236
[TBL] [Abstract][Full Text] [Related]
23. Buspirone and imipramine for the treatment of major depression in the elderly.
Schweizer E; Rickels K; Hassman H; Garcia-España F
J Clin Psychiatry; 1998 Apr; 59(4):175-83. PubMed ID: 9590668
[TBL] [Abstract][Full Text] [Related]
24. Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients.
Fabre L; Birkhimer LJ; Zaborny BA; Wong LF; Kapik BM
Int Clin Psychopharmacol; 1996 Jun; 11(2):119-27. PubMed ID: 8803649
[TBL] [Abstract][Full Text] [Related]
25. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.
Claghorn JL; Earl CQ; Walczak DD; Stoner KA; Wong LF; Kanter D; Houser VP
J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826
[TBL] [Abstract][Full Text] [Related]
26. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
Fabre LF
J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
[TBL] [Abstract][Full Text] [Related]
27. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
Feighner JP; Boyer WF
J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
[TBL] [Abstract][Full Text] [Related]
28. A comparative study of sertraline versus imipramine in postpsychotic depressive disorder of schizophrenia.
Kirli S; Caliskan M
Schizophr Res; 1998 Sep; 33(1-2):103-11. PubMed ID: 9783350
[TBL] [Abstract][Full Text] [Related]
29. Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group.
Versiani M; Amrein R; Stabl M
Int Clin Psychopharmacol; 1997 Jul; 12(4):183-93. PubMed ID: 9347378
[TBL] [Abstract][Full Text] [Related]
30. Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.
Mehtonen OP; Søgaard J; Roponen P; Behnke K
J Clin Psychiatry; 2000 Feb; 61(2):95-100. PubMed ID: 10732656
[TBL] [Abstract][Full Text] [Related]
31. The treatment of severe depression: is there an efficacy gap between SSRI and TCA antidepressant generations?
Nierenberg AA
J Clin Psychiatry; 1994 Sep; 55 Suppl A():55-9; discussion 60-1, 98-100. PubMed ID: 7961543
[TBL] [Abstract][Full Text] [Related]
32. The long-term outcome of dysthymia in private practice: clinical features, temperament, and the art of management.
Haykal RF; Akiskal HS
J Clin Psychiatry; 1999 Aug; 60(8):508-18. PubMed ID: 10485632
[TBL] [Abstract][Full Text] [Related]
33. Sexual function in postpartum women treated for depression: results from a randomized trial of nortriptyline versus sertraline.
Lanza di Scalea T; Hanusa BH; Wisner KL
J Clin Psychiatry; 2009 Mar; 70(3):423-8. PubMed ID: 19284932
[TBL] [Abstract][Full Text] [Related]
34. A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients.
Sechter D; Troy S; Paternetti S; Boyer P
Eur Psychiatry; 1999 Mar; 14(1):41-8. PubMed ID: 10572324
[TBL] [Abstract][Full Text] [Related]
35. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
Schweizer E; Feighner J; Mandos LA; Rickels K
J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
[TBL] [Abstract][Full Text] [Related]
36. Combined treatment with venlafaxine and tricyclic antidepressants in depressed patients who had partial response to clomipramine or imipramine: initial findings.
Gómez Gómez JM; Teixidó Perramón C
J Clin Psychiatry; 2000 Apr; 61(4):285-9. PubMed ID: 10830150
[TBL] [Abstract][Full Text] [Related]
37. The pharmacotherapy of depressive illness in adolescents: an open-label comparison of fluoxetine with imipramine-treated historical controls.
Strober M; DeAntonio M; Schmidt-Lackner S; Pataki C; Freeman R; Rigali J; Rao U
J Clin Psychiatry; 1999 Mar; 60(3):164-9. PubMed ID: 10192591
[TBL] [Abstract][Full Text] [Related]
38. Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone.
Elliott AJ; Russo J; Bergam K; Claypoole K; Uldall KK; Roy-Byrne PP
J Clin Psychiatry; 1999 Apr; 60(4):226-31. PubMed ID: 10221282
[TBL] [Abstract][Full Text] [Related]
39. Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial.
Keller MB; Kocsis JH; Thase ME; Gelenberg AJ; Rush AJ; Koran L; Schatzberg A; Russell J; Hirschfeld R; Klein D; McCullough JP; Fawcett JA; Kornstein S; LaVange L; Harrison W
JAMA; 1998 Nov; 280(19):1665-72. PubMed ID: 9831997
[TBL] [Abstract][Full Text] [Related]
40. Black and white patients response to antidepressant treatment for major depression.
Varner RV; Ruiz P; Small DR
Psychiatr Q; 1998; 69(2):117-25. PubMed ID: 9627929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
